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Department of Physics and Astronomy, Rice University, Houston, TexasABSTRACT Schafmeister, Po, and Verdine (another study) introduced a method using a hydrocarbon linker (staple) to stabi-
lize a peptide in a helical configuration. One intended goal of this scheme is to facilitate the delivery of peptide drugs into target
cells. Here, we investigate whether stapled peptides are intrinsically membrane permeable, by performing a case study on a
stapled 12-mer peptide named NYAD-1. We found that the native peptide CAI (an HIV-1 inhibitor) does not bind to lipid bilayers,
however NYAD-1 indeed permeates through lipid bilayers even at low solution concentrations. To understand the reason for the
membrane permeability, we investigated the physical properties of NYAD-1 as a function of bound peptide/lipid molar ratio P/L.
We found that NYAD-1 spontaneously binds to a lipid bilayer. At low P/L, the peptide primarily binds on the polar-apolar interface
with its helical axis parallel to the bilayer, which has the effect of stretching the membrane area and thinning the membrane. The
membrane thinning reaches its maximum at P/L ~1/15–1/12 in DOPC bilayers. Additional bound peptides have little thinning
effect and their helical axes are normal to the plane of bilayers. Thus, the stapled peptide has a membrane interaction behavior
similar to helical antimicrobial peptides, such as magainin and melittin. We emphasize that not all peptides that bind to lipid bi-
layers in the a-helical form behave this way.INTRODUCTIONThe lipid matrix of a cell membrane provides a hydrophobic
barrier that defines the boundary of the cell. An intact mem-
brane is crucial for cell function but it is also a major imped-
iment for the delivery of therapeutic agents into cells. This is
so even if the drug enters the cell by endocytosis—in such a
case, the drug still needs to cross the endosomal membrane.
In recent years a new type of drug technology called stapled
peptides has been developed and adopted by the pharmaceu-
tical industry. An all-hydrocarbon staple cross-links a pep-
tide at i and iþ4 or iþ7 position to increase its a-helix
propensity (1–7). The rationale for the stapled peptides is
threefold (1): 1), stabilizing the peptide in a configuration
that matches the binding site of the protein target, 2), pro-
tecting the peptide against proteolytic action, and 3),
making the peptide membrane permeable. Although the
functionality and stability of stapled peptides are under-
standable, it is not clear why the stapled helicity would facil-
itate cell uptake. Notably these stapled peptides bypass the
Lipinski rules, which stipulate that the molecular mass of
a drug should not exceed 500 Da (6,8). Stapled peptides
are several times that size, and yet still traffic to the intracel-
lular targets (2,4,7). The goal of our study is to investigate
first, if the peptides indeed gain membrane permeability
by the stapling modification, and second, if so what could
be the underlying mechanism for the membrane permeation.
We hope to provide a rational basis for the use of this new
drug delivery technology. Understanding the mechanism
for membrane permeation will facilitate the development
of strategies for drug delivery.Submitted September 24, 2012, and accepted for publication March 26,
2013.
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0006-3495/13/05/1923/10 $2.00We studied a stapled peptide called NYAD-1 based on a
12-mer peptide capsid assembly inhibitor (CAI) that has
been found to target the capsid of human immunodeficiency
virus type 1 (HIV-1). CAI inhibits HIV-1 assembly in vitro;
however, it failed to inhibit HIV-1 in cell culture. The x-ray
crystal structure of CAI in complex with the C-terminal
domain of capsid revealed that the peptide adopts an a-he-
lical conformation (4,9). Accordingly, Zhang et al. (4)
used the hydrocarbon stapling technique (1–3) to convert
CAI into a stable helical peptide named NYAD-1. Subse-
quently, the authors showed the anti-HIV-1 activity of
NYAD-1 in cell culture and that the stapled peptide indeed
targeted the C-terminal domain of capsid. However, cellular
uptake is not a proof of self-permeation through the mem-
brane. For example, cellular uptake of various cell-pene-
trating peptides has been widely reported, yet the
mechanisms of cell-penetrating peptides are still being
debated (10,11).
With a fluorescence-labeled NYAD-1 (named NYAD-2)
we found that the peptide indeed permeates across lipid bi-
layers. To understand what properties of the peptide enable
the membrane permeability, we studied NYAD-1mixed in
lipid bilayers as a function of the peptide/lipid ratio. We
compare the results with antimicrobial peptides and amyloid
precursor peptides. We discuss the important properties of
NYAD-1 that make the peptide membrane permeable.EXPERIMENT
Materials
NYAD-1 is H - Ile - Thr - Phe - X - Asp - Leu - Leu - X - Tyr -
Tyr - Gly - Pro - NH2 (with special cyclization to get double
bond, X ¼ (S) - alpha - (20-pentenyl)alanine) (4). NYAD-1http://dx.doi.org/10.1016/j.bpj.2013.03.039
1924 Sun et al.and CAI (H-Ile-Thr-Phe-Glu-Asp-Leu-Leu-Asp-Tyr-Tyr-
Gly-Pro-NH2) were synthesized by CPC Scientific (San
Jose, CA) under the supervision of Xiaohe Tong, one of
the authors of (4). NYAD-2 is FITC - (beta - Ala) - Ile -
Thr - Phe - X - Asp - Leu - Leu - X - Tyr - Tyr - Gly - Pro
- NH2 (with special cyclization to get double bond,
X ¼ (S) - alpha - (20- pentenyl)alanine; FITC ¼ fluorescein
isothiocyanate) synthesized by AnaSpec (Fremont, CA).
The chemical structures of NYAD-1 and NYAD-2 (4)
are reproduced in Fig. 1. 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)
(Rh-DOPE) were purchased from Avanti Polar Lipids
(Alabaster, AL). Texas Red sulfonyl chloride (TRsc) (MW
625), Texas Red dextran (TRD) (MW 10,000), and calcein
(MW 623) were purchased from Invitrogen (Grand Island,FIGURE 1 The sequence of CAI and, in the box, the synthesis of
NYAD-1 and FITC-NYAD-1(also called NYAD-2), reproduced with
permission from (4).
Biophysical Journal 104(9) 1923–1932NY). Fluorescein PEG (MW 1000), was purchased from
NANOCS (Boston, MA). All other chemicals were pur-
chased from Sigma-Aldrich (St. Louis, MO) and were
used without further purification. All experiments were per-
formed at room temperature ~25C unless specified
otherwise.
Giant unilamellar vesicles (GUVs) were produced by the
electroformation method (12) in a production chamber con-
taining a GUV interior solution. The solution includes
~200 mM sugar (sucrose or glucose) to control the osmo-
lality, a pH buffer and solution dyes if necessary. A typical
GUV experiment was performed with GUVs containing
~200 mM sucrose inside, in an outside solution of
~200 mM glucose. The refractive index contrast between
sucrose and glucose makes the GUVs visible and the density
contrast makes the GUVs sink to the bottom of the solution
for the ease of manipulation. The osmolalities of the solu-
tions used for the GUV interior and GUV exterior were
measured separately by a Wescor model 5520 dew-point
Osmometer (Wescor, Logan, UT). Equiosmolality between
the inside and outside of the GUV was the initial condition
in all GUV experiments. To produce GUVs, DOPC or
DOPC and 0.5% molar ratio of Rh-DOPE (for clear
imaging) were dissolved in 1:1 (v/v) tetrafluoroethylene
and chloroform. The lipid solution (~0.05 mg lipid) was
deposited onto two indium tin oxide (ITO)-coated glass
coverslips. After drying under vacuum, an o-ring was sand-
wiched between the two ITO slips and the gap was filled
with the interior solution. 3 V ac at 10 Hz was applied
between the two ITO electrodes for 2 h. Subsequently, the
frequency was adjusted to 5 Hz for 10 min and followed
by 1 Hz for 10 min. This electroformation method has
been shown to produce unilamellar large vesicles (12).
The GUV suspension was then gently collected in a glass
vial (reservoir). The vesicles were used within 24 h of
production.
Aligned multilamellae of peptide/lipid mixtures were
prepared by first dissolving the peptide and lipid at a chosen
molar ratio, P/L, in 1:1 (v/v) tetrafluoroethylene and chloro-
form. The mixture was uniformly spread on a thoroughly
cleaned fused-quartz substrate (0.018 mg peptide on a
1 cm2 quartz plate for P/L > 1/30; 0.3 mg of lipid on a
1 cm2 plate for P/L % 1/30). After the solvent evaporated
in vacuum, the sample was hydrated with saturated water
vapor in a 37C oven overnight. The results were well-
aligned parallel bilayers, as proven by x-ray diffraction
(XRD). During the experiment, the samples were housed
in a temperature humidity chamber in which the hydration
level of the sample was controlled by the relative humidity
(RH) of water vapor (13).Aspirated GUV experiment
The experimental setup for the aspirated GUV experiment
was described in Sun et al (14). Before the experiment,
Stapled Helical Peptides 1925micropipettes (with inner diameter 16–20 mm) and the walls
of sample chambers were coated with 0.5% bovine serum
albumin to dissipate the charge on the glass surface and
then washed extensively with water. The micropipette was
connected to an oil-filled U tube where a negative pressure
was produced and controlled by reference to the atmosphere
pressure (15).
A selected GUV (diameter ~30–70 mm) in the reservoir
was aspirated at a low constant negative pressure
(~100 Pa producing a membrane tension ~0.4 mN/m) by
a micropipette, and transferred via a transfer pipe (14) to
an observation chamber where the solution contained the
peptide. Note that CAI, NYAD-1, or NYAD-2 was added
to the solution by first dissolving in dimethylsulfoxide
(DMSO) (the DMSO concentration in the experimental
chamber was 2 to 7 mM). It is known that DMSO perme-
ates through lipid bilayers (16). To avoid the effect of
DMSO on osmolality balance (16), the same concentration
of DMSO was also added to the interior solution, so that the
osmolality of the solution in the observation chamber was
the same as in the GUV interior solution. The response of
the GUV to the peptide binding was observed by a conven-
tional inverted widefield microscope (IX81, Olympus,
Tokyo, Japan) and recorded by a Hamamatsu Photonics
digital CCD Camera (model C10600-10B) (Hamamatsu
City, Japan), or by a confocal microscopy (Nikon C1 si-
LU4A confocal spectral imaging system and Nikon C2
confocal laser point scanning system—Tokyo, Japan) with
488 nm/561 nm lasers (OBIS/Sapphire, Coherent, Santa
Clara, CA).
In response to peptide binding, a GUV can potentially
change its membrane area A and volume V. The GUV
protrusion inside the micropipette serves as an amplifier
for the measurement of such changes. From the microscopic
images, Lp the length of the protrusion, Rp the radius of
the micropipette, and Rv the radius of the GUV were
carefully measured. It is then straightforward to
show DA ¼ 2pRpDLp þ 8pRvDRv, and DV ¼ pR2pDLpþ
4pR2vDRv (17). If there is no molecular leakage and as
long as the inside and outside of the GUV have the same
osmolality, there should be no change of volume. Under
the condition DV ¼ 0, DLp is directly proportional to DA:
DA ¼ 2pRpð1 Rp=RvÞDLp.
On the other hand, if peptides induce formation of trans-
membrane pores, the influx of glucose will be greater than
the efflux of sucrose through the pores, because sucrose is
approximately two times as large as glucose. The resultant
osmolality imbalance induces a net water influx, causing a
volume increase in the GUV (18). (Conversely if sucrose
and glucose were exchanged, the GUV volume decreased
(14).) If the membrane area is constant, the relation between
DLp and DV is DV ¼ pRpðRv  RpÞDLp. Thus, if peptides
induce pores in the membrane, the GUV protrusion length
would decrease, DLp<0, after the peptide binding has
reached equilibrium (18,19).GUV dye leakage experiment
For the leakage experiment, the GUV interior solution also
contained 30 mM calcein and 50 mM TRD10,000. Two
observation chambers containing the same solution
190 mM glucose and 10 mM HEPES pH 7 were set side
by side. About 10 mL of the GUV suspension was injected
into the first observation chamber and well mixed with the
solution in the chamber by stirring. About 10 GUVs were
transferred from the first to the second chamber via a trans-
fer pipe. The purpose of this two-chamber procedure was to
dilute the untrapped calcein and TRD in the solution
external to the GUVs. In the second chamber, the GUVs
settled at the bottom due to the density differential and
were observed by a widefield microscope. The effect of pep-
tide-induced leakage was observed by slowly injecting
a small amount of exterior solution containing NYAD-1
into the chamber until the peptide concentration equal to
25 mM. Slow injection (for ~30 s) was necessary to not
create a flow in the observation chamber.Peptide permeation experiment
We used FITC-labeled NYAD (called NYAD-2) to observe
membrane permeation. Like many fluorescent dyes, the fluo-
rescence intensity of NYAD-2 is pH dependent. In particular,
we found that the intensity at pH 9 is 1.78 times higher than
at pH 7. We decided to use this property to help measure
the intensity of permeated NYAD-2 inside the GUV.
The permeation experiment was performed as follows.
The interior solution for GUV production was 190 mM su-
crose, 10 mM Tris at pH 9, 10 mM TRsc, and 2.82 mM
DMSO. Two chambers each contained 190 mM glucose,
10 mM Tris at pH 7, and 2.82 mM DMSO were set side
by side, one for control and one for observation. Only the
observation chamber contained 2 mM NYAD-2. A GUV
aspirated from the production chamber was first transferred
to the control chamber to dilute the untrapped TRsc in the
exterior solution, and then transferred to the observation
chamber for observation under a confocal microscope.
The image was recorded in two channels: 488 nm for
FITC and 561 nm for TRsc. The recording time was 0.5 s
every minute to avoid excessive photobleaching. A negative
control was performed with the same conditions with
NYAD-2 replaced by fluorescein PEG (1000).
For the pH 9 experiment, GUVs were produced in a solu-
tion containing 190 mM sucrose, 20 mM TRsc, 7 mM
DMSO, and 10 mM Tris at pH 9. The solution in the obser-
vation chamber contained 190 mM glucose, 2 mMNYAD-2,
7 mM DMSO, 10 mM Tris at pH9. After GUVs were intro-
duced into the observation chamber, the chamber was sealed
to prevent water evaporation. This was necessary for a long
permeation time. The images were taken every hour manu-
ally by refocusing the microscope because of the slight
movement of the GUV.Biophysical Journal 104(9) 1923–1932
1926 Sun et al.The fluorescence intensities are corrected as follows. A
background intensity from the confocal system, in the
absence of the dye but with the same laser power, is sub-
tracted from every intensity reading—this intensity is B.
The solution dye intensity, IO, outside the GUV was practi-
cally constant (with negligible photobleaching). This is
because there was only one GUV (or ~10 GUVs in the
case pH 9 experiment) in a chamber of ~700 mL; the total
number of bound NYAD-2 is <106 (or 105) of the total
in solution. Because of the imperfection of confocality, there
is an influence of the dye on the GUV surface to the interior
fluorescence intensity. This was estimated by comparing the
interior intensities of GUVs with and without lipid dye
(NBD-DOPE) on the surface. The interior intensity is
increased by 4% of the intensity averaged over the GUV
surface, IS. Similarly, the interior intensity is influenced
by the external solution intensity, which was estimated by
the interior reading with fluorescein PEG (1000) outside
the GUV. The interior reading is 20% of the external
reading. Thus, the intensity of GUV interior, II , is corrected
by 1), the system background, 2), the effect of surface
intensity, and 3), the effect of outside intensity:
IcI ¼ II  B 0:04IS  0:2IO. The corrected solution dye in-
tensity outside of the GUV is IcO ¼ IO  B.XRD experiment
Multilamellar samples were measured in a temperature-
humidity chamber (13). u-2q diffraction was collected on
a four-circle Huber goniometer (Huber Diffraktionstechnik,
Rimsting, Germany), with a vertical line-focused Cu Ka
source (l ¼ 1.542 A˚) operating at 35 kV and 15–30 mA.
The incident beam was collimated by a horizontal soller
slit and two vertical slits on the front and the back sides
of the soller slit. The horizontal and vertical divergences
of the incident beam were 0.23 and 0.3, respectively.
The diffracted beam first passed through a vertical slit and
then was discriminated by a bent graphite monochromator
(selected for 1.542 A˚) before entering a scintillation detec-
tor. Thus, the detector excluded Compton scattering, fluo-
rescence, and most of the x-rays from air scattering. This
diffractometer was designed to minimize the background
signal, thus allowing the measurement of high diffraction
orders.
Before the measurement, the aligned multilayer sample
was carefully positioned at the center of the x-ray beam
and was oriented so that u ¼ 0 and q ¼ 0 coincided.
We have established an elaborate routine for positioning
and orienting the sample as described in Wu et al. (20). A
two-dimensional u-q scan around the second or the third
Bragg order was used to check the alignment of the u-angle
and the mosaic of the multilayers alignment. Typically, the
full width at half-maximum of the peak on the u axis (of the
u-q scan) was 0.2–0.3 (example in (21)). Once the sample
was properly positioned and aligned on the diffractometer,Biophysical Journal 104(9) 1923–1932each u-2q scan was performed from u ¼ 0.5 to u ¼ 7.5
with a step size of Du ¼ 0.01. An attenuator was used to
prevent the first-order Bragg peak from saturating the detec-
tor. The scan was repeated 2–3 times at each of several
hydration levels and averaged at each hydration level for
data analysis. Measurements at several hydration levels
were for the purpose of phase determination by the swelling
method. Only the results of 98–100% RH are reported.
(Note that the readings of commercial humidity sensors
are not accurate above 98% RH; we used the maximum
RH above which the membrane samples would flow.)
The procedure of data reduction was described in many of
our previous works (22,23). Briefly, the measured diffrac-
tion intensity was first corrected for the attenuator absorp-
tion and for the detector’s dead-time factor. After
removing the background, data were corrected for sample
absorption and diffraction volume. The integrated peak in-
tensities were then corrected for the polarization and the
Lorentz factors. The relative magnitude of the diffraction
amplitude was the square root of the integrated intensity.
With their phases determined by the swelling method, the
diffraction amplitudes were used to reconstruct the electron
density profile of the bilayer. Across the bilayer profile, the
phosphate peak to phosphate peak distance (PtP) was
measured for the bilayer thickness. Measurements by the
previously described procedure have been applied to various
peptide-lipid mixtures for more than a decade, e.g.,
(20,21,23).Oriented circular dichroism (OCD)
CD spectra were measured in a Jasco (Tokyo, Japan) J-810
Spectropolarimeter. Aligned multilamellar samples of
NYAD-1 in DOPC bilayers were kept fully hydrated in a hu-
midity chamber with quartz windows. The substrates were
oriented normal to the incident light for the measurement
of OCD (24). Each sample was measured at least 5 times
and averaged. The background spectrum for each sample
was measured for the same amount of lipid on the same sub-
strate. After the background correction, the spectra of
different P/L were normalized by the amount of peptide.
For comparison, a solution CD of NYAD-1 was measured
in Tris buffer pH 8 in the presence of 35% (v/v) acetonitrile
at a final peptide concentration of 424 mM (following the
protocol given in (4)). (Note that DMSO absorbs ultraviolet,
not usable for CD measurement.)RESULTS
Aspirated GUV experiment
Aspirated GUV experiment is useful for understanding the
general behavior of a new membrane-acting molecule. To
begin, if the molecule binds to lipid bilayers, we can expect
an expansion of the membrane area. The consequence of
Stapled Helical Peptides 1927molecular binding may vary. The molecule could simply
incorporate into the lipid bilayer, e.g., curcumin(16). The
molecule could form pores in the membrane, e.g., melittin
(19). The molecule could turn into aggregates, e.g., penetra-
tin (25). The molecule could extract lipid molecules from
the bilayer, e.g., tea catechin (14). These general character-
istics of interaction with membranes have been shown for a
great variety of lipid compositions, with the only differences
in the P/L dependence (26). Thus, we have arbitrarily cho-
sen DOPC for our investigation. The initial experiment
with an aspirated GUV was to provide a qualitative under-
standing of how NYAD interacts with membranes. We
observed what happened to the membrane exposed to
NYAD. Equally important was what did not happen to the
GUV, for example peptide-lipid aggregates on the GUV
surface.
Fig. 2 shows separately the responses of a DOPC GUV to
CAI, NYAD-1, and NYAD-2 all at the same concentration
8 mM in pH 7 solutions. There was no indication of CAI
binding to the GUV over a long time (Fig. 2 A). The very
slow increase of the protrusion length was the same as in
a control run with no peptide (see Fig. 2D). The background
increase (in the absence of peptides) was caused by a slow
increase of osmolality in the exterior solution due to waterFIGURE 2 An aspirated GUVof DOPC (and 0.5% molar ratio of Rh-DOPE) w
or 8 mM NYAD-2 (C) at pH 7. The length of the GUV protrusion into the micro
parison, DLp was converted to the fractional area change DA=A by the relation D
similar to the control runs without peptides, as shown in (D). (B and C) With NYA
length reached a maximum, it steadily decreased; this indicates pore formation. S
similar results. (D) The protrusion length change was converted to DA=A for CA
lines)—2 runs are shown for each. The osmolalities of the internal and external so
control was due to water evaporation from the external solution. (E) DA=A vs. tim
NYAD-2 experiment. In (E and F), a decreasing DA=A is used to indicate poreevaporation. A higher osmolality in the exterior solution
caused an efflux of water from the GUV. A decrease of
GUV volume at constant membrane area caused an increase
of the protrusion length. This background protrusion length
increase is added to the protrusion length increase caused by
peptide binding. We normally design our experiment to fin-
ish within a few minutes to avoid this complication (for
example, using anionic lipids to increase the binding rate
to cationic peptides). Here, we let the experiment last for
30 min to make sure there is no membrane binding by
CAI. The experiment with CAI was repeated many times
at different peptide concentrations (highest 40 mM) with
the same result, all similar to control runs. The conclusion
is that CAI has negligible binding affinity to lipid bilayers.
In the presence of 8 mM NYAD-1, the protrusion length
increased and reached a maximum within 15 s (Fig. 2 B
and Fig. 2 E). This membrane area increase implies peptide
binding. After reaching the maximum, the protrusion length
decreased indicating that pores were formed in the mem-
brane as explained in the Experiment section. Although
the cause of the protrusion length decrease was due to
pore formation, the beginning of pore formation was not
coincidental with the point of maximum protrusion length.
Because of the continuing peptide binding, which continuedas introduced into a solution containing 8 mMCAI (A), 8 mMNYAD-1 (B),
pipette, Lp, was measured at regular time intervals. For the purpose of com-
A ¼ 2pRpð1 Rp=RvÞDLp. (A) With CAI, the protrusion length increase is
D-1/NYAD-2, the protrusion length increased initially. After the protrusion
cale bar¼ 25 mm. Experiments A, B, and C were repeated several times with
I (square dots, solid lines) compared with controls (round dots and dashed
lutions of GUVs were initially balanced. The protrusion length increase in a
e for 4 runs of the NYAD-1 experiment. (F) DA=A vs. time for 3 runs of the
formation, not a decrease in membrane area.
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1928 Sun et al.to increase the protrusion length, the protrusion length did
not immediately decrease as soon as pores appeared.
The same experiment was repeated for NYAD-2 (Fig. 2
C) to show that the FITC label on NYAD-1 did not alter
the peptide’s characteristic property (Fig. 2, E and F). The
modification by the FITC label slowed the action of the pep-
tide considerably, indicating a lower binding affinity to the
bilayer (note the timescale). Nevertheless, NYAD-2 also
caused the protrusion length to increase to a maximum fol-
lowed by a steady decrease, showing its pore forming
capability.Dye leakage experiment
This experiment was performed to confirm the observation
of pore formation in aspirated GUVs. Fig. 3 shows molecu-
lar leakage induced by NYAD-1 at high concentrations. A
GUV containing green dye calcein (MW 623) and red dye
TRD (MW 10,000) was transferred to the observation cham-
ber. NYAD-1 dissolved in the external solution was slowly
injected into the observation chamber until its final concen-
tration was 25 mM. After a while both dyes were observed to
leak out, whereas the GUV membrane remained intactFIGURE 3 AGUV (DOPC) containing green dye calcein (MW 623) and
red dye TRD (MW 10,000) was in a solution of pH 7. NYAD-1 was injected
slowly (a duration of ~30 s) into the solution until it reached 25 mM. Time
zero was at the beginning of peptide injection. The time of leakage de-
pended on the distance between the injector and the GUV and the speed
of injection; it should not be compared with Fig. 2 B. Both dyes started
to leak out at the same time. Scale bar ¼ 50 mm.
Biophysical Journal 104(9) 1923–1932(Fig. 3). The time of leakage depended on the position of
the injector relative to the GUV and the speed of injection.
Understandably, the leakage of calcein was faster than
TRD10,000 due to the difference in molecular weight.
When the same leakage experiment was performed with
antimicrobial peptide magainin, the pores at first allowed
both large and small dye molecules to leak out but after a
while only small molecules continued to leak out, implying
a pore size reduction with time (27). It is not clear from our
leakage curves whether the large dye would leak out
completely. The pore size kinetics was not pursued, because
it is probably of no interest to the therapeutic use of
NYAD-1 at much lower concentrations.NYAD permeation experiment
Because NYAD peptide forms pores at high concentrations,
the permeation experiment was conducted at a low peptide
concentration, 2 mM, to avoid pore formation. However,
the fluorescence intensity of NYAD-2 at this concentration
was too weak for the permeation measurement. We tested
and found that the fluorescence intensity of NYAD-2 at
pH 9 is 1.78 times higher than at pH 7. To make use of
this pH effect, we produced GUVs with a pH 9 solution in
the lumen and performed the permeability experiment in
pH 7 solutions.
An aspirated GUV was first imaged in the control cham-
ber (which contained no NYAD-2) right before it was trans-
ferred to the observation chamber. It took ~1.5 min to
readjust the confocal focus after the transfer. Therefore,
the first fluorescence measurement was taken ~1.5 min after
the GUV was exposed to 2 mMNYAD-2. The time sequence
of images is shown in Fig. 4 A. The protrusion length
increased without any sign of decrease, indicating peptide
binding without molecular leakage. The absence of molec-
ular leakage was reconfirmed by the constant intensity of
TRsc inside the GUV (Fig. 4 B). The steady increase of
the FITC fluorescence intensity inside the GUV clearly in-
dicates permeation of NYAD-2 through the GUV mem-
brane. However, after the normalization by the effect of
pH 9 (i.e., dividing the corrected inside intensity by 1.78),
we were surprised to find the normalized intensity of
NYAD-2 inside the GUV greater than the intensity outside
after ~30 min (Fig. 4 B).
This unusual phenomenon could be explained by a
possible pH-effect on the concentration dependence of the
chemical potential. If the peptide can permeate through
the membrane, the chemical potential of NYAD-2 will
approach an equal value inside and outside. However, the
concentration dependence of the chemical potential could
be different for pH 7 and pH 9.
We also performed a permeation experiment with a pH 9
solution both inside and outside of GUV, so that there was
no differential pH effect. Fig. 5 shows the result. Clearly
the fluorescence intensity of NYAD-2 inside the GUV
FIGURE 4 (A) Confocal images of an aspirated
GUV (DOPC) containing a pH 9 solution and
10 mM TRsc (red) in the lumen, first in the control
chamber (t < 0) and then transferred to the obser-
vation chamber (time 0) containing a solution of
2 mM NYAD-2 (green) at pH 7. The binding of
NYAD-2 (the green intensity on the GUV bound-
ary increased with time) caused the membrane
expansion (protrusion length increase) with no mo-
lecular leakage. (The bright, thin, horizontal red
bar on the micropipette was an optical artifact.)
Scale bar¼ 20 mm. (B) Relative intensities of fluo-
rescence: Red for TRsc inside the GUV (normal-
ized to one at t ¼ 0); Black for the corrected
solution intensity of NYAD-2 outside the GUV,
IcO (also normalized to one at time ¼ 0); Green
for the corrected intensity of NYAD-2 inside the
GUV divided by the corrected intensity outside
averaged over time, IcO (and divided by 1.78 due
to the pH 9 effect): IcI =ðIcO  1:78Þ. Note that the
corrected intensity inside the GUV exceeded the
corrected outside intensity after ~30 min.
Stapled Helical Peptides 1929increased with time and it approached ~60% of the outside
intensity after ~7 h, whereas the fluorescence intensity of
the interior dye TRsc was constant. NYAD-2 permeated
through the lipid bilayer without causing molecular leakage.
We did not feel it was necessary to continue this manual
experiment any longer to prove the permeation of
NYAD-2. For a negative control, the pH 7-pH 9 permeation
experiment was performed with fluorescein PEG (1000)
replacing NYAD-2. As expected, no fluorescein PEG was
detected inside the GUV.Membrane thinning by NYAD-1 binding
Electron density profiles obtained by XRD show that the
peptide-lipid mixtures formed well-defined lipid bilayers(Fig. 6, A and B). The electron density of the peptides
did not show up in the diffraction-constructed profiles,
because the peptide positions were not correlated from
bilayer to bilayer (diffraction is the result of electron density
correlations (28)). The most important effect of peptide
binding is measured by the phosphate peak to phosphate
peak distance across the bilayer (PtP). PtP is a measure of
the bilayer thickness. It decreases more or less linearly
with P/L up to a value P/L* between 1/15 and 1/12, and
levels off for P/L > P/L* (Fig. 6 C). Previous studies with
antimicrobial peptides (AMPs) (29,30) showed that AMPs
caused a linear decrease of PtP with P/L and followed by
a PtP leveling off, similar to NYAD-1. Neutron in-plane
scattering showed that transmembrane pores were formed
in the bilayers for P/L > P/L* but no pores were detectedFIGURE 5 Peptide permeation experiment in a
pH 9 solution both inside and outside the GUV
(DOPC). The top row shows the green channel im-
ages for the intensity of NYAD-2, and the bottom
row the red channel for the intensity of TRsc.
The observation chamber was sealed to keep the
water from evaporation (hence no micropipette
aspiration). The TRsc intensity was essentially
constant in 7 h. The inside to outside intensity ra-
tios for NYAD-2, IcI =I
c
O, increased from a few
percent in the first image to ~60% after ~7 h.
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FIGURE 6 X-ray lamellar diffraction of NYAD-
1/DOPC mixtures in a series of P/L. (A) Raw data
of the diffraction patterns. (B) Electron density
profiles of the bilayers: Z is the distance from the
bilayer center. (C) The phosphate peak to phos-
phate peak distance across the bilayer, PtP,
measured for a series of P/L. The error bars are
that of reproducibility using two to three indepen-
dently prepared samples.
1930 Sun et al.for P/L < P/L* (31–33). Thus, for AMPs, P/L* is the
threshold concentration for pore formation.
Membrane thinning in proportion to P/L implies that pep-
tides bind on the bilayer interface. Due to the near incom-
pressibility of the hydrocarbon volume in the chain region
of lipid bilayer (34), the area expansion is accompanied
by a corresponding membrane thinning. Thus, the linear
thinning detected by x-ray corresponds to the initial mem-
brane expansion detected in the aspirated GUVexperiment.FIGURE 7 OCD of NYAD-1 in a series of P/L and a solution CD for
comparison. OCD spectra are mutually normalized to the same amount
of peptide; the solution CD (red) was superimposed by matching a long
wavelength region to the OCDs. The OCD spectra imply that the
NYAD-1 helices are parallel to the bilayer for P/L % 1/20. A fraction of
NYAD-1 helices are oriented normal to the bilayer for P/LR 1/15.OCD measurement
Although NYAD-1 is only 12 amino-acids long, its solution
CD is no different from a normal a-helical spectrum
(Fig. 7). Its OCD spectra are also similar to that of longer
peptides (Fig. 7). The method of OCD was explained in
great detail in Wu et al. (24). The most prominent feature
for a-helices is the orientation dependence of the p-p* tran-
sition near 208 nm. The electric transition dipole for this
band is polarized along the helical axis, therefore the band
magnitude is largest when the helices are perpendicular to
the light or parallel to the plane of membrane and vanishes
when the helices are in the direction of light or perpendic-
ular to membrane (24). The magnitude of the n-p* transition
near 224 nm also decreases (but not vanishes), because the
helices change from parallel to perpendicular orientation
relative to the plane of membrane. Fig. 7 shows that for
all values of P/L % 1/20, the OCD spectra of NYAD-1
are identical and have the largest 208 nm amplitude
(compared with the OCD at higher P/Ls), consistent with
the peptide helices being parallel to the bilayer at low
P/Ls. The decrease of 208 nm amplitude for P/L R 1/15
indicate that a fraction of NYAD-1 helices changed toBiophysical Journal 104(9) 1923–1932normal orientation, and this fraction increased with P/L.
The transition point where a fraction of helices begin to
change orientation from parallel to perpendicular is between
P/L ¼ 1/20 and 1/15, which is reasonably close to the mem-
brane thinning transition point (P/L between 1/15 and 1/12)
where membrane thinning levels off (Fig. 6 C). In many
other peptide experiments, we found that these two transi-
tion points were in agreement within experimental errors
(29,30,35).
Stapled Helical Peptides 1931Note that a solution CD is the orientational average of the
OCD spectra and is equivalent to a mixture of 1/3 of helices
normal to the bilayer and 2/3 of helices parallel to the
bilayer (this was proven both theoretically and experimen-
tally in (24)). The shape of the solution CD is between the
OCD spectra at P/L ¼ 1/15 and 1/10.DISCUSSION
These experimental methods have been used in the past to
discover at least four different types of membrane-active
molecules. Our intention is to compare NYAD-1 with
them. Curcumin induces a nonlinear membrane thinning
as a function of P/L; its binding states are a combination
of interfacial state and chain insertion state; it has no other
effects on the membrane (16,36). Tea catechin induces a
linear membrane thinning; it binds only to the interface of
membranes but also solubilizes the lipid molecules (14).
Amyloid peptide penetratin binds to membranes as an a-he-
lix and induces a linear membrane thinning until P/L rea-
ches a critical value P/L*; additional peptide binding (P/L
> P/L*) would turn the peptides into b-sheet aggregates
and come off the external surface of GUV (25,35). AMPs
induce a linear membrane thinning until P/L reaches P/L*;
additional peptide binding (P/L > P/L*) causes pore
formation. Clearly, the membrane interaction behavior of
NYAD-1 is closely similar to AMPs.
First, we found that both NYAD-1 and NYAD-2 bound to
the lipid bilayer and expanded the membrane area, whereas
the native peptide CAI did not. To distinguish whether the
peptide binding is on the bilayer’s polar-apolar interface
or into the lipid chain region, we performed XRD experi-
ment. The result showed that the membrane thickness
decreased linearly in proportion to P/L. This implies that
the initial binding is on the bilayer interface. However,
when P/L exceeds P/L*, the membrane thinning levels off,
exactly in the same manner as AMPs. The dye leakage
experiment showed that NYAD-1 formed pores in the mem-
brane but left the GUV intact.A method for measuring membrane permeability
To detect the membrane permeability of NYAD, we used the
dye-labeled NYAD-2, which we have shown to have the
same membrane interaction as NYAD-1, i.e., binding to
the membrane and causing membrane leakage at high P/L.
To overcome the weak fluorescence intensity in low concen-
trations (e.g., 2 mM), we exploited the pH dependence of
FITC fluorescence whose intensity at pH 9 is 1.78 times
higher than at pH 7. A previous experiment by Zhou and
Raphael (37) showed there was little change in the bilayer
elastic properties between pH 7 and pH 9.
The peptide permeation experiment was performed by
introducing GUVs containing a pH 9 solution into a solution
of NYAD-2 at pH 7. The result (Fig. 4 A) clearly shows thatNYAD-2 peptides permeated through the membrane,
whereas the integrity of the membrane was assured by no
decrease of the GUV protrusion length (see the Experi-
mental section on aspirated GUVs) and no leakage of
TRsc. Permeation was also demonstrated with pH 9 solu-
tions both inside and outside of the GUV, in the absence
of differential pH effect. This method of membrane perme-
ability measurement could be useful for other membrane-
active molecules.Membrane-bound states and membrane
permeability
At low concentrations, the membrane-bound state of
NYAD-1 is on the bilayer interface. Nevertheless, the pep-
tide can translocate across the bilayer. Thus, we conclude
that the hydrocarbon-stapling has imparted three essential
characteristics to NYAD-1 that are relevant to its membrane
permeability. First, the hydrocarbon link provides an amphi-
phathic molecular surface to the otherwise hydrophilic pep-
tide. CAI has negligible binding affinity to lipid bilayers,
whereas NYAD-1 has a strong affinity for membrane bind-
ing. Second, NYAD-1 has a membrane interacting property
similar to AMPs. Third, the hydrocarbon stapling prevents
the peptide from turning into b-sheet aggregates; the possi-
bility of forming amyloids could deprive a peptide of its
membrane permeability, as in the case of penetratin (25,35).
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